Singapore markets closed
Straits Times Index
3,313.48 +8.49 (+0.26%) Nikkei
38,787.38 -132.88 (-0.34%) Hang Seng
19,553.61 +177.08 (+0.91%) FTSE 100
8,420.26 -18.39 (-0.22%) Bitcoin USD
66,969.31 -79.99 (-0.12%) CMC Crypto 200
1,369.25 -4.59 (-0.33%)
STOK May 2024 12.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
At close: 03:54PM EDT
| Previous close | 1.6500 |
| Open | 1.5500 |
| Bid | 0.9500 |
| Ask | 1.8500 |
| Strike | 12.50 |
| Expiry date | 2024-05-17 |
| Day's range | 1.1500 - 1.6500 |
| Contract range | N/A |
| Volume | |
| Open interest | 1.05k |
Business WireStoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
BEDFORD, Mass., May 17, 2024--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today announced that, effective on May 15, 2024, the company granted stock options of common stock to Thomas Leggett, the Company’s newly-appointed Chief Financial Officer, and four other new employees as a material inducement to their employment in accordance with Nasdaq Listing
GuruFocus.comStoke Therapeutics Inc (STOK) Reports Q1 2024 Financial Results: A Closer Look at Challenges ...
Despite Narrow Miss on EPS, Stoke Therapeutics Advances in Clinical Developments
Simply Wall St.Stoke Therapeutics First Quarter 2024 Earnings: Beats Expectations
Stoke Therapeutics ( NASDAQ:STOK ) First Quarter 2024 Results Key Financial Results Net loss: US$26.4m (loss widened by...
© 2024 Yahoo. All rights reserved.